TIGIT and liver cancer: Dmitrij Ostroumov et al. found anti-TIGIT inhibitors can produce a synergistic inhibitory effect and inhibit the growth of liver cancer in mice with normal immune function, when combined with anti-PD-1 inhibitors [41].